Skip to main content

Front Row Advisors LLC

SEC CIK
0001729254
Latest filing
Aug 13, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
24,207
Value
$6.05M
% of portfolio
1.8%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Front Row Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202624,207$6.05M1.8%−997−4.0%ReducedHolders
Q1 202625,204$5.48M1.9%+66+0.3%AddedHolders
Q4 202525,138$5.74M1.9%−328−1.3%ReducedHolders
Q3 202525,466$5.90M2.0%−349−1.4%ReducedHolders
Q2 202525,815$4.79M1.7%−263−1.0%ReducedHolders
Q1 202526,078$5.46M2.1%−878−3.3%ReducedHolders
Q4 202426,956$4.79M1.7%−116−0.4%ReducedHolders
Q3 202427,072$5.35M1.9%−274−1.0%ReducedHolders
Q2 202427,346$4.69M1.6%+265+1.0%AddedHolders
Q1 202427,081$4.93M1.8%+269+1.0%AddedHolders
Q4 202326,812$4.16M1.9%−426−1.6%ReducedHolders
Q3 202327,238$4.06M1.9%−507−1.8%ReducedHolders
Q2 202327,745$3.74M1.7%+39+0.1%AddedHolders
Q1 202327,706$4.42M2.1%+318+1.2%AddedHolders
Q4 202227,388$4.43M2.3%−1,099−3.9%ReducedHolders
Q3 202228,487$3.82M2.0%−83−0.3%ReducedHolders
Q2 202228,570$4.38M2.2%−185−0.6%ReducedHolders
Q1 202228,755$4.66M1.9%+40+0.1%AddedHolders
Q4 202128,715$3.89M1.5%+857+3.1%AddedHolders
Q3 202127,858$3.00M1.3%−43−0.2%ReducedHolders
Q2 202127,901$3.29M1.3%+385+1.4%AddedHolders
Q1 202127,516$2.98M1.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.